A.I.-Based Platform for Clinical Decision Workflows Launches
RetinAI US, Inc., via its parent company Ikerian AG, announced the launch of the artificial intelligence-based RetinAI Discovery for Clinics…
RetinAI US, Inc., via its parent company Ikerian AG, announced the launch of the artificial intelligence-based RetinAI Discovery for Clinics…